Generali Asset Management SPA SGR Purchases Shares of 431 Teleflex Incorporated (NYSE:TFX)

Generali Asset Management SPA SGR purchased a new stake in Teleflex Incorporated (NYSE:TFX) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 431 shares of the medical technology company’s stock, valued at approximately $77,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Diamond Hill Capital Management Inc. purchased a new position in shares of Teleflex during the fourth quarter worth about $46,696,000. Cooke & Bieler LP grew its holdings in shares of Teleflex by 22.1% during the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock worth $191,962,000 after purchasing an additional 195,150 shares during the last quarter. Janus Henderson Group PLC grew its holdings in shares of Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after purchasing an additional 147,147 shares during the last quarter. FMR LLC grew its holdings in shares of Teleflex by 70.1% during the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after purchasing an additional 111,086 shares during the last quarter. Finally, Point72 Asset Management L.P. grew its holdings in shares of Teleflex by 31.2% during the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after purchasing an additional 96,958 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Price Performance

Shares of TFX opened at $141.77 on Friday. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.91. The stock’s 50 day moving average is $163.17 and its two-hundred day moving average is $194.40. The firm has a market capitalization of $6.57 billion, a PE ratio of 28.19, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.96%. Teleflex’s payout ratio is 95.77%.

Analyst Ratings Changes

Several brokerages have issued reports on TFX. Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. Wells Fargo & Company lowered their price target on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. Royal Bank of Canada lowered Teleflex from an “outperform” rating to a “sector perform” rating and lowered their price target for the stock from $220.00 to $155.00 in a report on Friday, February 28th. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Finally, Morgan Stanley lowered their price target on Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Teleflex has an average rating of “Hold” and a consensus target price of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.